Search Results 1461-1470 of 18704 for Relapse
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...
Understanding who is more likely to have a relapse of lymphoma and why. Finding ways to improve quality of life after lymphoma treatment. Publications. See a ...
Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer Scottsdale/Phoenix, ...
counseling, group support and medical lectures. Topics include relapse prevention, mindfulness and the physiology of addiction. “You've got to get away from ...
This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal ...
The primary purpose of this study is to compare 1 year graft-versus-host disease (GVHD)-free, graft relapse-free survival (GRFS) between the two GVHD ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Hypo ...
relapsed or refractory AML. Safety and efficacy have not been established children younger than 2 years of age with relapsed or refractory AML. Geriatric.
HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORS. ... Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 ...
This study aims to determine if any of three new GVHD prophylaxis approaches improves the rate of GVHD and relapse free survival at one year after ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.